Company: HCWB
Filing Date: 2025-02-07
Form Type: 8-K
Source: 0000950170-25-016390
Chunk: 1

Company: HCW Biologics Inc.
Filing Date: 2025-02-07
Form: 8-K
Item: Item 3.01
Chunk 1
---
 Company following the hearing. At the hearing, the Company will present its plan to evidence compliance with all applicable listing criteria, including the MVLS Rule, the Bid Price Rule and the MVPHS Rules; however, there can be no assurance that the Panel will grant the Company’s request for continued listing or that the Company will be able to evidence compliance within the period of time that may be granted by the Panel. The Panel has the authority to grant the Company an extension of up to 180 days from the date of the Nasdaq Staff’s determination letter the Company received on December 17, 2024. The Company is considering all options available to it to regain compliance with all Listing Rules; however, there can be no assurance that the Panel will grant the Company’s request for continued listing or that the Company will be able to evidence compliance within the period of time that may be granted by the Panel.

Item 8.01 Other Events.